Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white

S A Back1, N L Luo, N S Borenstein

  • 1Department of Pediatrics, Oregon Health Sciences University, Portland, Oregon 97201, USA. Backs@ohsu.edu

Insights

Periventricular leukomalacia (PVL) in premature infants disrupts oligodendrocyte development. The late oligodendrocyte progenitor stage, before myelination begins, is most vulnerable to hypoxic-ischemic injury, increasing cerebral palsy risk.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Neonatal Neurology

Background:

  • Periventricular leukomalacia (PVL) is a leading cause of brain injury in premature infants, resulting in cerebral palsy.
  • PVL is characterized by chronic myelination disturbances, indicating disrupted oligodendrocyte (OL) lineage progression due to ischemic injury.

Purpose of the Study:

  • To identify the specific oligodendrocyte lineage stages vulnerable to injury during the critical developmental window for PVL (23-32 weeks postconceptional age).
  • To understand the relationship between OL development, myelination onset, and PVL risk in the periventricular white matter.

Main Methods:

  • Analysis of 26 normal control human autopsy brains (18-41 weeks postconceptional age).
  • Characterization of oligodendrocyte lineage stages using specific antibodies (anti-NG2, O4, O1, anti-MBP) in the parietal white matter.
  • Quantification of OL progenitor and immature OL populations and assessment of myelination.

Main Results:

  • Late oligodendrocyte progenitors (NG2+O4+) were the predominant stage throughout late gestation.
  • Immature oligodendrocytes (O4+O1+) increased significantly between 28-41 weeks, coinciding with the onset of myelination (MBP+).
  • The high-risk window for PVL (23-32 weeks) precedes significant myelination and is characterized by a high proportion of late OL progenitors.

Conclusions:

  • The late oligodendrocyte progenitor is the primary target of hypoxic-ischemic injury during the vulnerable window for PVL.
  • The decline in PVL incidence around 32 weeks correlates with the onset of myelination, suggesting myelination offers some protection.
  • Understanding OL vulnerability is crucial for developing strategies to prevent PVL and subsequent cerebral palsy in premature infants.